Mid-stage neu­ro­science start­up En­grail rais­es $157M

En­grail Ther­a­peu­tics is rid­ing a neu­ro­science tail­wind.

Last year as it set out to raise its lat­est fundrais­ing round, the start­up orig­i­nal­ly tar­get­ed $100 mil­lion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER